Clinical Trial Update: Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TAK-875 in combination with sitagliptin in adults with type 2 diabetes has completed, with results reported on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)
• TAK-875 (fasiglifam)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED